Trial Profile
Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route in Comparison With Intramuscular Vaccination With Vaxigrip in Adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2014
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi; Sanofi Pasteur
- 17 Jul 2008 New trial record.